Literature DB >> 21847514

[Receptor detection in breast cancer. A decade of quality assurance trials in German-speaking pathology].

H H Kreipe.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21847514     DOI： 10.1007/s00292-011-1522-3

Source DB:  PubMed          Journal:  Pathologe        ISSN： 0172-8113            Impact factor:   1.011


× No keyword cloud information.
  6 in total

1.  Quality assurance in immunohistochemistry: results of an interlaboratory trial involving 172 pathologists.

Authors:  Thomas Rüdiger; H Höfler; H-H Kreipe; H Nizze; U Pfeifer; H Stein; F E Dallenbach; H-P Fischer; M Mengel; R von Wasielewski; H K Müller-Hermelink
Journal:  Am J Surg Pathol       Date:  2002-07       Impact factor: 6.394

2.  Tissue array technology for testing interlaboratory and interobserver reproducibility of immunohistochemical estrogen receptor analysis in a large multicenter trial.

Authors:  Reinhard von Wasielewski; Michael Mengel; Birgitt Wiese; Thomas Rüdiger; Hans Konrad Müller-Hermelink; Hans Kreipe
Journal:  Am J Clin Pathol       Date:  2002-11       Impact factor: 2.493

3.  Inter-laboratory and inter-observer reproducibility of immunohistochemical assessment of the Ki-67 labelling index in a large multi-centre trial.

Authors:  Michael Mengel; Reinhard von Wasielewski; Birgitt Wiese; Thomas Rüdiger; Hans Konrad Müller-Hermelink; Hans Kreipe
Journal:  J Pathol       Date:  2002-11       Impact factor: 7.996

4.  The CD117 immunohistochemistry tissue microarray survey for quality assurance and interlaboratory comparison: a College of American Pathologists Cell Markers Committee Study.

Authors:  David M Dorfman; Marilyn M Bui; Raymond R Tubbs; Eric D Hsi; Patrick L Fitzgibbons; Michael D Linden; Robert R Rickert; Patrick C Roche
Journal:  Arch Pathol Lab Med       Date:  2006-06       Impact factor: 5.534

5.  Proficiency testing of immunohistochemical biomarker assays in breast cancer.

Authors:  Reinhard von Wasielewski; Svenja Hasselmann; Josef Rüschoff; Annette Fisseler-Eckhoff; Hans Kreipe
Journal:  Virchows Arch       Date:  2008-10-29       Impact factor: 4.064

6.  Quality assessment of HER2 testing by monitoring of positivity rates.

Authors:  Harald Choritz; Guntram Büsche; Hans Kreipe
Journal:  Virchows Arch       Date:  2011-08-02       Impact factor: 4.064
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.